Chemoinformaics analysis of 20-Hydroxyecdysone 22-acetate
| Molecular Weight | 522.679 | nRot | 6 |
| Heavy Atom Molecular Weight | 476.311 | nRig | 22 |
| Exact Molecular Weight | 522.319 | nRing | 4 |
| Solubility: LogS | -2.824 | nHRing | 0 |
| Solubility: LogP | 1.751 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 85.5185 |
| nHD | 5 | BPOL | 49.6195 |
| QED | 0.264 |
| Synth | 5.378 |
| Natural Product Likeliness | 2.901 |
| NR-PPAR-gamma | 0.393 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.053 |
| Pgp-sub | 0.215 |
| HIA | 0.759 |
| CACO-2 | -4.883 |
| MDCK | 0.0000163 |
| BBB | 0.931 |
| PPB | 0.747225 |
| VDSS | 0.909 |
| FU | 0.181916 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.121 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.752 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.338 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.094 |
| CYP3a4-sub | 0.562 |
| CL | 2.35 |
| T12 | 0.204 |
| hERG | 0.011 |
| Ames | 0.074 |
| ROA | 0.858 |
| SkinSen | 0.019 |
| Carcinogencity | 0.028 |
| EI | 0.008 |
| Respiratory | 0.192 |
| NR-Aromatase | 0.694 |
| Antiviral | Yes |
| Prediction | 0.697384 |